Compare LPL & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LPL | STVN |
|---|---|---|
| Founded | 1985 | 1949 |
| Country | South Korea | Italy |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Containers/Packaging |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.7B |
| IPO Year | 2004 | 2021 |
| Metric | LPL | STVN |
|---|---|---|
| Price | $3.17 | $19.68 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 3 |
| Target Price | N/A | ★ $25.67 |
| AVG Volume (30 Days) | ★ 3.1M | 267.4K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.39% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.35 | $9.67 |
| Revenue Next Year | $2.94 | $9.99 |
| P/E Ratio | ★ $25.64 | $27.15 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.16 | $12.89 |
| 52 Week High | $5.83 | $28.00 |
| Indicator | LPL | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 33.43 | 57.51 |
| Support Level | N/A | $18.74 |
| Resistance Level | $4.37 | $20.27 |
| Average True Range (ATR) | 0.14 | 0.78 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 5.97 | 55.63 |
LG Display Co Ltd manufacture TFT-LCD and OLED technology-based display panels in a broad range of sizes and specifications mainly for use in IT products (comprising notebook computers, desktop monitors and tablet computers), televisions, mobile devices, including smartphones, as well as auto products, and it are one of the world's suppliers of large-sized OLED television panels. It also manufacture display panels for industrial and other applications, including entertainment systems and medical diagnostic equipment.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.